SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 151.68 |
| Enterprise Value ($M) | 162.49 |
| Book Value ($M) | 71.09 |
| Book Value / Share | 1.45 |
| Price / Book | 2.13 |
| NCAV ($M) | 7.18 |
| NCAV / Share | 0.15 |
| Price / NCAV | 21.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.15 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.40 |
| Current Ratio | 1.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 156.82 |
| Assets | 220.72 |
| Liabilities | 149.63 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | BlackRock, Inc. | 7.80 | 0.00 | |
| 13G | Frazier Life Sciences Public Fund, L.P. | 5.40 | ||
| 13G/A | Camber Capital Management LP | |||
| 13G/A | Vanguard Group Inc | 7.99 | 5.94 | |
| 13G/A | Acorn Bioventures, L.p. | 6.20 | 7.10 | |
| 13G/A | Millennium Management Llc | 6.70 | 18.21 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 76,857 | 817,185 | 9.41 | |
| 188,183 | 815,860 | 23.07 | |
| 120,290 | 890,943 | 13.50 | |
| 137,854 | 753,132 | 18.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ORIC – ORIC Pharmaceuticals, Inc. | OVID – Ovid Therapeutics Inc. |
| PASG – Passage Bio, Inc. | PCRX – Pacira BioSciences, Inc. |
| PCVX – Vaxcyte, Inc. |